The Journal of Community and Supportive Oncology - 16(5)

Finding that sweet spot where science, practice, and best-possible outcomes come together

Nivolumab and ipilimumab combination promises new standard of care for advanced RCC

Venetoclax approved to treat CLL patients regardless of genotype

Effect of time of admission to treatment initiation on outcomes of patients with acute myeloid leukemia: a tertiary care referral center experience

Marriage predicts for survival in patients with stage III non–small-cell lung cancer

Primary renal synovial sarcoma – a diagnostic dilemma

Prolonged survival in adenocarcinoma of unknown primary treated with chemoradiotherapy

Game changers in pediatric cancer

Collaboration is key to bridging the AYA cancer care divide

Advances in precision medicine help refine – and redefine – cancer care